14-day Premium Trial Subscription Sign Up For FreeGet Free

Ardelyx Stock Forecast NASDAQ:ARDX

Price Target and Analyst Ratings

Most Recent Rating

On July 30, 2021 "Cantor Fitzgerald" gave "$14.00 - $7.00" rating for ARDX. The price target was changed from $1.71 to 1.2%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-07-30 $14.00 - $7.00 Target Lowered by Cantor Fitzgerald $1.74 $1.71→1.2%
2021-07-21 $16.00 - $7.00 Target Lowered by Citigroup $1.93 $2.01→73.9%
2021-07-21 $11.00 - $2.00 Downgraded by Jefferies Financial Group $1.93 $2.01→73.9%
2021-07-20 $7.70 Target Set by Cowen $2.01 $1.94→74.8%
2021-07-20 $3.00 Downgraded by Wedbush $2.01 $7.70+2.7%
2021-07-20 $6.50 - $15.00 Target Raised by LADENBURG THALM/SH SH $2.01 $7.70+2.7%
2021-07-20 $14.00 - $4.00 Downgraded by Piper Sandler $2.01 $7.70+2.7%
2021-07-20 Reiterated by Cowen $2.01 $7.70+2.7%
2021-03-29 Outperform Initiated by Wedbush $6.10 $14.00
2021-03-22 Outperform Initiated by Wedbush $6.93
2021-01-05 Overweight Initiated by Cantor Fitzgerald $6.35
2020-12-11 Outperform Target Raised by SVB Leerink $6.68 $11.00 → $14.00
2020-06-17 Buy Reiterated by Cowen $6.89

ARDX Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.08 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $-2.40 $-0.23 $1.95
2021-09-21 $-2.54 $-0.36 $1.82
2021-09-22 $-2.67 $-0.49 $1.68
2021-09-23 $-2.80 $-0.63 $1.55
2021-09-24 $-2.94 $-0.76 $1.41
2021-09-27 $-3.07 $-0.89 $1.28
2021-09-28 $-3.20 $-1.03 $1.15
2021-09-29 $-3.34 $-1.16 $1.01
2021-09-30 $-3.47 $-1.30 $0.88
2021-10-01 $-3.61 $-1.43 $0.75
2021-10-04 $-3.74 $-1.56 $0.61
2021-10-05 $-3.87 $-1.70 $0.48
2021-10-06 $-4.01 $-1.83 $0.35
2021-10-07 $-4.14 $-1.96 $0.21
2021-10-08 $-4.27 $-2.10 $0.0777
2021-10-11 $-4.41 $-2.23 $-0.0560
2021-10-12 $-4.54 $-2.37 $-0.19
2021-10-13 $-4.68 $-2.50 $-0.32
2021-10-14 $-4.81 $-2.63 $-0.46
2021-10-15 $-4.94 $-2.77 $-0.59
2021-10-18 $-5.08 $-2.90 $-0.72
2021-10-19 $-5.21 $-3.03 $-0.86
2021-10-20 $-5.34 $-3.17 $-0.99
2021-10-21 $-5.48 $-3.30 $-1.13
2021-10-22 $-5.61 $-3.44 $-1.26
2021-10-25 $-5.75 $-3.57 $-1.39
2021-10-26 $-5.88 $-3.70 $-1.53
2021-10-27 $-6.01 $-3.84 $-1.66
2021-10-28 $-6.15 $-3.97 $-1.79
2021-10-29 $-6.28 $-4.10 $-1.93

About Ardelyx

Ardelyx Ardelyx, Inc. discovers, develops, and commercializes minimally-systemic therapeutics for the gastrointestinal (GI) tract to treat GI and cardio-renal diseases. Its lead product candidate is tenapanor, which is in Phase III clinical trial for the treatment of patients with constipation-predominant irritable bowel syndrome, as well as in Phase IIb clinical trial for the treatment of hyperphosphatemia or elevated serum phosphorus levels in patients... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT